ArticleInternational journal of obesity (2005)2021

Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity.

Leo Sungwong Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.